You just read:

Findings from AcelRx Pharmaceuticals' Phase 3 SAP301 Study of ARX-04 in Abdominoplasty Patients to be Presented at Plastic Surgery Meeting

News provided by

AcelRx Pharmaceuticals, Inc.

Sep 22, 2016, 16:01 ET